A Case Report: Subanesthetic Ketamine Infusion for Treatment of Cancer-Related Pain Produces Urinary Urge Incontinence

Barbara A. Vickers; Wayne Lee; Joann Hunsberger

doi:10.1213/XAA.0000000000000472

A Case Report: Subanesthetic Ketamine Infusion for Treatment of Cancer-Related Pain Produces Urinary Urge Incontinence

Barbara A. Vickers, Wayne Lee, Joann Hunsberger

School of Medicine

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

Oncology patients undergoing treatment can experience substantial pain related to their disease or prescribed therapy. Ketamine infusions at subanesthetic doses have been used at our institution to supplement the pain management regimens of 262 patients. We present 2 cases in which young adult patients being treated with subanesthetic ketamine for cancer-related pain experienced urinary urgency and incontinence after initiation or increase of the ketamine infusion. This adverse effect has not been reported previously at this dosing range. These case reports suggest that subanesthetic ketamine infusions may cause side effects that previously have been reported only at anesthetic or abuse doses.

Original language	English (US)
Pages (from-to)	219-221
Number of pages	3
Journal	A & A case reports
Volume	8
Issue number	9
DOIs	https://doi.org/10.1213/XAA.0000000000000472
State	Published - May 1 2017

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1213/XAA.0000000000000472

Cite this

@article{6e0cae770fb24610aa9f69b6e3373935,

title = "A Case Report: Subanesthetic Ketamine Infusion for Treatment of Cancer-Related Pain Produces Urinary Urge Incontinence",

abstract = "Oncology patients undergoing treatment can experience substantial pain related to their disease or prescribed therapy. Ketamine infusions at subanesthetic doses have been used at our institution to supplement the pain management regimens of 262 patients. We present 2 cases in which young adult patients being treated with subanesthetic ketamine for cancer-related pain experienced urinary urgency and incontinence after initiation or increase of the ketamine infusion. This adverse effect has not been reported previously at this dosing range. These case reports suggest that subanesthetic ketamine infusions may cause side effects that previously have been reported only at anesthetic or abuse doses.",

author = "Vickers, {Barbara A.} and Wayne Lee and Joann Hunsberger",

year = "2017",

month = may,

day = "1",

doi = "10.1213/XAA.0000000000000472",

language = "English (US)",

volume = "8",

pages = "219--221",

journal = "A & A case reports",

issn = "2325-7237",

publisher = "Lippincott Williams and Wilkins",

number = "9",

}

TY - JOUR

T1 - A Case Report

T2 - Subanesthetic Ketamine Infusion for Treatment of Cancer-Related Pain Produces Urinary Urge Incontinence

AU - Vickers, Barbara A.

AU - Lee, Wayne

AU - Hunsberger, Joann

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Oncology patients undergoing treatment can experience substantial pain related to their disease or prescribed therapy. Ketamine infusions at subanesthetic doses have been used at our institution to supplement the pain management regimens of 262 patients. We present 2 cases in which young adult patients being treated with subanesthetic ketamine for cancer-related pain experienced urinary urgency and incontinence after initiation or increase of the ketamine infusion. This adverse effect has not been reported previously at this dosing range. These case reports suggest that subanesthetic ketamine infusions may cause side effects that previously have been reported only at anesthetic or abuse doses.

AB - Oncology patients undergoing treatment can experience substantial pain related to their disease or prescribed therapy. Ketamine infusions at subanesthetic doses have been used at our institution to supplement the pain management regimens of 262 patients. We present 2 cases in which young adult patients being treated with subanesthetic ketamine for cancer-related pain experienced urinary urgency and incontinence after initiation or increase of the ketamine infusion. This adverse effect has not been reported previously at this dosing range. These case reports suggest that subanesthetic ketamine infusions may cause side effects that previously have been reported only at anesthetic or abuse doses.

UR - http://www.scopus.com/inward/record.url?scp=85038247977&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038247977&partnerID=8YFLogxK

U2 - 10.1213/XAA.0000000000000472

DO - 10.1213/XAA.0000000000000472

M3 - Article

C2 - 28118213

AN - SCOPUS:85038247977

SN - 2325-7237

VL - 8

SP - 219

EP - 221

JO - A & A case reports

JF - A & A case reports

IS - 9

ER -

A Case Report: Subanesthetic Ketamine Infusion for Treatment of Cancer-Related Pain Produces Urinary Urge Incontinence

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this